Payment overview · 2025
General Payments
$17.52
1 reported records · 1 companies
Healthcare provider profile · identity verified
Cooper Stewart, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · KANSAS CITY, MO · NPI 1699123901
Verified facts
What the public records show
CMS Open Payments records show Cooper Stewart, M.D. received $17.52 in general payments during 2025 across 1 reported records.
Insulet Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Insulet Corporation | Unresolved — no canonical attribution shown | $17.52 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.52 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $17.52 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 584 | 153 |
| Lisinopril | Lisinopril | 392 | 104 |
| Omeprazole | Omeprazole | 391 | 91 |
| Gabapentin | Gabapentin | 314 | 63 |
| Levothyroxine Sodium | Levothyroxine Sodium | 307 | 72 |
| Amlodipine Besylate | Amlodipine Besylate | 277 | 70 |
| Losartan Potassium | Losartan Potassium | 231 | 60 |
| Trazodone Hcl | Trazodone Hcl | 223 | 49 |
| Metformin Hcl | Metformin Hcl | 208 | 56 |
| Escitalopram Oxalate | Escitalopram Oxalate | 187 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 179 | 41 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 177 | 45 |
| Potassium Chloride | Potassium Chloride | 174 | 48 |
| Naproxen | Naproxen | 172 | 58 |
| Metformin Hcl Er | Metformin Hcl | 169 | 41 |
| Sertraline Hcl | Sertraline Hcl | 166 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 37 |
| Prednisone | Prednisone | 141 | 100 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 139 | 50 |
| Carvedilol | Carvedilol | 137 | 28 |
| Furosemide | Furosemide | 136 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 132 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 129 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 127 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 123 | 39 |
| Simvastatin | Simvastatin | 123 | 34 |
| Eliquis | Apixaban | 109 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 105 | 37 |
| Alendronate Sodium | Alendronate Sodium | 104 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 104 | 29 |
| Allopurinol | Allopurinol | 101 | 26 |
| Meloxicam | Meloxicam | 98 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 93 | 22 |
| Pregabalin | Pregabalin | 86 | 18 |
| Alprazolam | Alprazolam | 85 | 19 |
| Famotidine | Famotidine | 85 | 19 |
| Jardiance | Empagliflozin | 84 | 14 |
| Montelukast Sodium | Montelukast Sodium | 84 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 78 | 20 |
| Novolog Flexpen | Insulin Aspart | 77 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 74 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 70 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 70 | 13 |
| Tramadol Hcl | Tramadol Hcl | 70 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 69 | 11 |
| Lorazepam | Lorazepam | 61 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 60 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 60 | 44 |
| Ozempic | Semaglutide | 60 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 58 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 57 | 15 |
| Atenolol | Atenolol | 55 | 18 |
| Ibuprofen | Ibuprofen | 54 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 53 | 16 |
| Propranolol Hcl | Propranolol Hcl | 52 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 49 | 46 |
| Januvia | Sitagliptin Phosphate | 48 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 48 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 26 |
| Sucralfate | Sucralfate | 47 | 13 |
| Glimepiride | Glimepiride | 46 | 13 |
| Cephalexin | Cephalexin | 45 | 27 |
| Tresiba Flextouch U-100 | Insulin Degludec | 45 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | suppressed |
| Azithromycin | Azithromycin | 42 | 36 |
| Buspirone Hcl | Buspirone Hcl | 42 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 42 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 42 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | suppressed |
| Baclofen | Baclofen | 41 | suppressed |
| Glipizide | Glipizide | 40 | 13 |
| Farxiga | Dapagliflozin Propanediol | 39 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 38 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | suppressed |
| Ezetimibe | Ezetimibe | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Myrbetriq | Mirabegron | 33 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 33 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 20 |
| Diazepam | Diazepam | 27 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 11 |
| Ketoconazole | Ketoconazole | 26 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 21 |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Mirtazapine | Mirtazapine | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Ondansetron Odt | Ondansetron | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Bumetanide | Bumetanide | 22 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Nystatin | Nystatin | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Xifaxan | Rifaximin | 13 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Erythromycin Ethylsuccinate | Erythromycin Ethylsuccinate | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Travoprost | Travoprost | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.52 · 1 records | Insulet Corporation | Omnipod | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error